Xingtai Infertility Specialist Hospital/Xingtai Reproduction and Genetics Specialist Hospital, Xingtai City, Hebei Province, China.
HEBEI INSTITUTE OF MECHANICAL AND ELECTRICAL TECHNOLOGY, Xingtai City, Hebei Province, China.
BMC Pregnancy Childbirth. 2023 Dec 16;23(1):865. doi: 10.1186/s12884-023-06173-5.
Polycystic ovary syndrome (PCOS) has unusual levels of hormones. The hormone receptors in the endometrium have a hostile effect and make the microenvironment unfavorable for embryo implantation. The use of gonadotropin stimulation during in vitro fertilization (IVF) may have an impact on embryo implantation and live birth rate. According to recent data, the clinical results of day 4 embryo transfer (D4 transfer) were on par with those of day 5 embryo transfer (D5 transfer) in IVF-ET. There are few studies comparing the outcomes of transplants with various etiologies and days. The purpose of this study was to determine which transfer day had the best result for PCOS patients undergoing IVF.
This retrospective cohort study was conducted in the Xingtai Infertility Specialist Hospital between January 2017 and November 2021. A total of 1,664 fresh ART cycles met inclusion criteria, including 242 PCOS transfers and 1422 tubal factor infertility transfers.
PCOS individuals had the highest live birth rate on D4 transferred. It was not need to culture embryos to blastocysts to optimize embryo transfer for PCOS women. This could be a novel approach to transplantation for PCOS.
多囊卵巢综合征(PCOS)患者的激素水平异常。子宫内膜中的激素受体具有拮抗作用,使微环境不利于胚胎着床。体外受精(IVF)中使用促性腺激素刺激可能会对胚胎着床和活产率产生影响。根据最近的数据,IVF-ET 中第 4 天胚胎移植(D4 移植)的临床结果与第 5 天胚胎移植(D5 移植)相当。比较不同病因和不同移植日的移植结局的研究较少。本研究旨在确定对于接受 IVF 的 PCOS 患者,哪一天的移植效果最佳。
本回顾性队列研究于 2017 年 1 月至 2021 年 11 月在邢台不孕不育专科医院进行。共有 1664 个新鲜的辅助生殖技术(ART)周期符合纳入标准,包括 242 个 PCOS 转移周期和 1422 个输卵管因素不孕转移周期。
PCOS 患者在 D4 移植时活产率最高。对于 PCOS 患者,无需将胚胎培养至囊胚即可优化胚胎移植。这可能是 PCOS 移植的一种新方法。